3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Thrombocythemia, Essential
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
34
Cyclophosphamide
31
Peripheral Blood Stem Cell Transplantation
27
Mycophenolic Acid
25
Cyclosporine
23
Antilymphocyte Serum
23
Busulfan
20
Tacrolimus
17
Radiotherapy
17
Filgrastim
17
Whole-Body Irradiation
15
Methotrexate
15
Methylprednisolone
14
Melphalan
13
Cord Blood Stem Cell Transplantation
12
venetoclax
9
Cytarabine
8
Azacitidine
8
fludarabine
5
Etoposide
5
sargramostim
4
Therapeutics
4
Sirolimus
4
Decitabine
4
Clofarabine
4
Alemtuzumab
4
thymoglobulin
3
nilotinib
3
merphos
2
Voriconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
INCB057643
×
Myeloid
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled